← SynDRA
degarelix
SynDRA canonical compound SYN0041941 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | GNRH1 | GNRHR |
|---|
| Mechanism of action | gonadotropin releasing factor hormone receptor antagonist |
|---|
| Indication | prostate cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- GNRHR ANTAGONIST
- Gonadotropin-releasing hormone receptor antagonist
- gonadotropin releasing factor hormone receptor antagonist
- GNRHR INHIBITOR
Drug classes
- Gonadotropin Releasing Hormone Receptor Antagonists
- Gonadotropin Releasing Hormone Receptor Antagonist
ATC classes
- L02B · HORMONE ANTAGONISTS AND RELATED AGENTS
Cross-references
Synonyms
- firmagon
- degarelix acetate
- FE200486 (FREE BASE)
- UNII-SX0XJI3A11
- SX0XJI3A11
- CHEMBL415606
- Uglypeptide1
- Degarelix (INN/USAN)
- Degarelix [USAN:INN:BAN]
- SCHEMBL1397034
- GTPL5585
- HSDB 7817
- CHEBI:135961
- HY-16168A
- BDBM50102450
- AKOS030526717
- AN-5181
- RL02641
- DB06699
- CS-5350
- FE200486 (AS ACETATE SALT)
- QC-10170
- Z-3147
- D08901
- 766D786
- Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-[Aph(DHor)]-D-[Aph(Cbm)]-Leu-ILys-Pro-DAla-NH2
- FE200486 ANHYDROUS FREE BASE
- DEGARELIX ACETATE
- FE-200486 (free base)
- FE-200486 ANHYDROUS FREE BASE
- degarelixum
- RefChem:58687
- L02BX02
- DTXCID801510614
- Firmagon
- FE200486
- FE200486 (free base)
- Degarelix [INN]
Reported adverse events
- Chills
- Constipation
- Dizziness
- Hypertension
- Arthralgia
- Asthenia
- Back pain
- Hyperhidrosis
- Injection site reaction
- Nausea
- Urinary tract infection
- Erectile dysfunction
Look up degarelix in the interactive SynDRA portal →